Power Law company profile

NovoCure

Biotech & Life Sciences · Root, Switzerland · Founded 2000 · IPO 2015 Unicorn

Novocure is a global oncology company pioneering a novel therapy for solid tumors. Patient images reflect patient(s) health status when photographed

Valuation

$1.56B

Market cap · May/2026

Revenue

$655M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

1 investor on NovoCure's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 1 investor entered at this stage

Technion Israel Institute of Technology

Global footprint

Where NovoCure has talent and traffic

AI talent share

0.7% of workforce is AI talent
(11 of 1,489 staff)

Core AI30.2%

Other AI80.54%

Non-AI workforce1,47899.26%

Workforce by country

26 countries with
team presence

🇺🇸 United States42.2%

🇮🇱 Israel18.9%

🇨🇭 Switzerland13.4%

🇩🇪 Germany7.6%

🇵🇱 Poland5.4%

Top 5 of 26 shown

Web traffic by country

48K monthly visits
across markets

🇺🇸 United States41.3%

🇵🇱 Poland8.3%

🇨🇭 Switzerland7.7%

🇬🇧 United Kingdom6.3%

🇫🇷 France6%

Top 5 markets shown

Patent intelligence

$409M patent portfolio · 443 active families

Estimated portfolio value

$409M

26.2% of market cap · comparable to top peer Insulet ($502M)

443 active patent families

Where NovoCure innovates Biomedical engineeringElectric fieldElectrodeCancer cellMechanical engineering

Where NovoCure concentrates vs peers

Each axis is a top-10 topic across NovoCure and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about NovoCure

An AI-synthesized read of the highest-engagement posts about NovoCure on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See NovoCure on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles